RGPX
REGENEREX PHARMA, INC.Company Information
- Company Name
- REGENEREX PHARMA, INC.
- CIK
- CIK0001357878
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- RGPX: OTC
- Fiscal Year End
- March 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- RGPX
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- —
- Price on filing date
- —
- 1-month reaction
- —
- 3-month reaction
- —
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 1 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | ||||||
| Finite Lived Intangible Assets Net | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Capitalized Computer Software Gross | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Machinery And Equipment Gross | 0 | - | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | ||||||
| Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Due To Related Parties Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | 1 | 1 | 1 | ||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Employee Related Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Notes Payable Current | - | - | - | - | - | - | - | 0 | 0 | - | - | - | ||||||
| Notes Payable Current | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Notes Payable | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Long Term Debt Noncurrent | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | ||||||
| Liabilities | 5 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 5 | 2 | 1 | 1 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 5 | 4 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -5 | -5 | -4 | -5 | -5 | -4 | -4 | -4 | -4 | -1 | -1 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -10 | -9 | -8 | -7 | -6 | -6 | -6 | -5 | -5 | -2 | -2 | -2 | ||||||
| Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Accumulated Amortization | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 675 | 675 | 675 | 675 | 675 | 675 | 675 | 675 | 675 | 675 | 675 | 675 | ||||||
| Common Stock Shares Issued | 282 | 281 | 281 | 278 | 278 | 278 | 278 | 278 | 278 | 277 | 277 | 277 | ||||||
| Shares Outstanding | 282 | 281 | 281 | 278 | 278 | 278 | 278 | 278 | 278 | 277 | 277 | 277 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialREGENEREX PHARMA, INC. (RGPX) — SEC Financial Statements & Analysis
REGENEREX PHARMA, INC. (RGPX) is a pharmaceutical preparations company, incorporated in NV. REGENEREX PHARMA, INC. trades on OTC as: RGPX. REGENEREX PHARMA, INC. (RGPX)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-17. Based on that filing, On profitability, REGENEREX PHARMA, INC. posts a Return on Equity (ROE) of 67.74% and a Return on Assets (ROA) of -512.11%. Per share, it reports EPS of $-0.01, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 135.66% year-over-year, and EPS growth of 133.00% year-over-year. On the balance sheet, it maintains a current ratio of 0.01x, a quick ratio of 0.00x, working capital of $-4.88M, a debt-to-equity ratio of -1.13x, a debt ratio of 8.61, an interest coverage ratio of -35.11x, free cash flow of $-2.44M (TTM), and net debt of $2.84M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-0.01
- ROE TTM
- 67.74%
- ROA TTM
- -512.11%
- Debt To Equity
- -1.13x
- Free Cash Flow TTM
- $-2.44M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is REGENEREX PHARMA, INC. in?
REGENEREX PHARMA, INC. (RGPX) operates in the Pharmaceutical Preparations industry.
What exchange does RGPX trade on?
REGENEREX PHARMA, INC. (RGPX) trades on the OTC.
Where is REGENEREX PHARMA, INC. incorporated?
REGENEREX PHARMA, INC. is incorporated in NV.
When was REGENEREX PHARMA, INC. (RGPX)'s most recent SEC filing?
REGENEREX PHARMA, INC. (RGPX)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-17.
What is RGPX's EPS (earnings per share)?
REGENEREX PHARMA, INC. (RGPX)'s trailing twelve month EPS is $-0.01 as of 2025-09-30.
What is RGPX's ROE (return on equity)?
REGENEREX PHARMA, INC. (RGPX)'s trailing twelve month Return on Equity (ROE) is 67.74% as of 2025-09-30.
What is RGPX's ROA (return on assets)?
REGENEREX PHARMA, INC. (RGPX)'s trailing twelve month Return on Assets (ROA) is -512.11% as of 2025-09-30.